Pharma-Bio Serv, Inc. (PBSV)
| Market Cap | 23.37M |
| Revenue (ttm) | 19.54M |
| Net Income (ttm) | n/a |
| Shares Out | 23.43M |
| EPS (ttm) | 0.13 |
| PE Ratio | 7.94 |
| Forward PE | n/a |
| Dividend | $0.08 (7.50%) |
| Ex-Dividend Date | n/a |
| Volume | 12,250 |
| Open | 1.02 |
| Previous Close | 1.06 |
| Day's Range | 0.96 - 1.04 |
| 52-Week Range | 0.88 - 1.87 |
| Beta | 0.32 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | n/a |
About PBSV
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto ...
Financial Performance
In 2020, PBSV's revenue was $21.56 million, an increase of 10.55% compared to the previous year's $19.51 million. Earnings were $2.05 million, a decrease of -1.74%.
Financial StatementsNews
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2021
DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer supp...
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2021
Announces Regulatory and Compliance Advisory Board DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project manag...
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2021
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting f...
Pharma-Bio Serv Announces Appointment of Kirk Michel as Chairman of the Board of Directors and Announces Special Divi...
DORADO, PUERTO RICO / ACCESSWIRE / January 5, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting ...
Pharma-Bio Serv: High Quality Nanocap For A Low Price
Pharma-Bio Serv is a cheap stock based on EV/EBIT with good earnings quality based on various multi-year metrics.